U.S. Parkinson's Disease Therapies Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented into dopamine agonists, levodopa / carbidopa, and other drugs for parkinson's disease. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

U.S. Parkinson's Disease Therapies Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Parkinson's Disease Therapies Markets, Parkinson's Disease OverviewDisease OverviewReport ScopeOverviewPrevalence and IncidenceClinical PresentationDiagnosisTreatment OverviewEvolution of PD TherapySurgical and Related OptionsGuidelines for Management of PDProduct and Pricing AnalysisU.S. Parkinson's Disease Therapies Markets, Total PD Therapies MarketsMarket DynamicsMajor Market DriversMajor Market RestraintsMarket Challenges and StrategiesMarket Engineering AnalysisMarket OverviewMarket Engineering MeasurementsCompetitive AnalysisMajor Market ParticipantsCompetitive StructureForecasts and TrendsDisease Progression StagesImpact of Current ScenarioImpact of New ProductsPatient ForecastsRevenue ForecastsFrost & Sullivan AwardsProduct Innovation AwardR&D Pipeline Leadership AwardEntrepreneurial Company AwardU.S. Parkinson's Disease Therapies Markets, Dopamine Agonists MarketCurrent DrugsDosage And Pricing AnalysisProduct AnalysisMarket Dynamics and ForecastsMarket DriversMarket RestraintsRevenue ForecastsU.S. Parkinson's Disease Therapies Markets, Levodopa/CarbidopaCurrent DrugsDosage And Pricing AnalysisProduct AnalysisMarket Dynamics and ForecastsMarket DriversMarket RestraintsRevenue ForecastsU.S. Parkinson's Disease Therapies Markets, Other PD Drugs MarketCurrent Products and PricingCOMT InhibitorsMAO-B InhibitorsNew Fixed Dose CombinationMarket Dynamics and ForecastsMarket DriversMarket RestraintsRevenue ForecastsPipeline AnalysisProducts in Phase III Clinical TrialsProducts in Phase II Clinical TrialsOther Promising Research




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.